Non-opioid Pain Treatment Market by Drug Class (NSAIDs, Acetaminophen, Local Anaesthetics), By Pain Type, By Route of Administration, By Distribution Channel, and by region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The global Non-opioid Pain Treatment Market size is projected to reach a CAGR of 7.1% from 2023-2030.
Non-opioid pain relievers are a form of pain reliever that has been specifically created to manage mild to moderate pain. They're commonly used to treat neuropathic pain, cancer pain, orthopaedic and musculoskeletal pain, and other conditions. Medical cannabis, botulinum toxins, capsaicin derivatives, and other non-opioid pain treatments are among the most common.
The rising global prevalence of osteoarthritis, fuelled by the ageing population, joint injuries, obesity, repeated stress on the joint, genetics, metabolic illnesses, and bone abnormalities, is expected to fuel demand for non-opioid pain treatment patches. The rising prevalence of chronic pain in India is expected to push the non-opioid pain patch market in South Asia. The market is expected to benefit from the government's increasing investments in the construction of a well-established healthcare infrastructure to treat pain-related disorders. Another important factor expected to boost the market is the growing demand for non-opioid pain management patches due to their ability to reduce the risk of addiction when compared to fentanyl patches when released over a lengthy period of time. In the foreseeable future, the rising demand for minimally invasive therapies is likely to boost growth
On the other hand, factors such as the high cost of patent drugs and the use of opioids in various underdeveloped and developing countries will hinder the non-opioid pain treatment market.
Due to the spread of COVID-19, the clinic's services were severely impacted by the nationwide lockdown and continued rise in infection rates across the country. Many pain and clinic services have seen a decrease in patient visits as a result of COVID-19, resulting in less client engagement. During COVID-19, several clinics and pain services saw a drop in the number of visits.
The growing incidence of chronic pain is due to the prevalence of server pain-causing conditions such as arthritis, cancer pain, and neuropathic pain. This created a demand for effective pain management solutions, where consumers looking for non-invasive and non-pharmacological methods to treat these kinds of pain that open up opportunities for non-opioid pain treatments. Further, the consumers are aware of the side effects and risks associated with opioid-based treatment which drives them to make use of non-opioid-based pain interventions. Moreover, the enhancement in alternative treatments such as nerve blockers, cannabinoids, alternative therapies like acupuncture and physical therapy, and government awareness programs on reducing opioid drug abuse continues to grow the market of non-opioid pain treatment in the next coming years.
North America to Dominate the Market